Manta Bidco v Mediclinic International PLC (LM106Sep22) [2023] ZACT 18 (24 March 2023)

Manta Bidco v Mediclinic International PLC (LM106Sep22) [2023] ZACT 18 (24 March 2023)

The Tribunal found that the proposed merger between Manta Bidco Ltd and Mediclinic International Plc does not substantially prevent or lessen competition in any relevant market. However, the transaction raises significant public interest considerations, particularly regarding the South African public healthcare sector, skills development, enterprise and supplier development, procurement from Black-owned businesses, capital expenditure, employment protection, and employee benefits. The Tribunal determined that these concerns could be adequately addressed through a comprehensive package of conditions, including commitments to perform pro bono surgeries, fund medical and nursing training,...

Citation
[2023] ZACT 18
Parties
Applicant: Manta Bidco Ltd; Respondent: Mediclinic International Plc
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
24 March 2023
Case Number
LM106Sep22
Procedural Posture
Merger Application / Tribunal Approval With Conditions
Outcome
Merger approved subject to public interest and information sharing conditions.
Legal Topics
Public Interest Conditions, Merger Control, Enterprise Development, Employment Protection, Information Sharing
Competition Law Commercial and Corporate Public Interest Conditions Merger Control Enterprise Development Employment Protection Information Sharing

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 1 Party arguments 2 Amounts and remedies 8
Sign in to unlock

Parties

Manta Bidco Ltd

Applicant

Mediclinic International Plc

Respondent

Procedural Posture

Merger Application / Tribunal Approval With Conditions

Legal Issues

  1. 1 Whether the proposed merger between Manta Bidco Ltd and Mediclinic International Plc should be approved under South African competition law.
  2. 2 Whether the merger raises public interest concerns requiring conditions.
  3. 3 Whether the transaction poses risks of anti-competitive information sharing post-merger.

Ratio Decidendi

The Tribunal found that the proposed merger between Manta Bidco Ltd and Mediclinic International Plc does not substantially prevent or lessen competition in any relevant market. However, the transaction raises significant public interest considerations, particularly regarding the South African public healthcare sector, skills development, enterprise and supplier development, procurement from Black-owned businesses, capital expenditure, employment protection, and employee benefits. The Tribunal determined that these concerns could be adequately addressed through a comprehensive package of conditions, including commitments to perform pro bono surgeries, fund medical and nursing training,...

Court Disposition

Merger approved subject to public interest and information sharing conditions.

Orders

  • The proposed merger between Manta Bidco Ltd and Mediclinic International Plc is approved subject to the conditions set out in the Tribunal's decision.
  • Mediclinic must perform at least 1000 pro bono surgeries in South Africa over the next five financial years.